Sason Hagit, Billard Jean Marie, Smith Garrick Paul, Safory Hazem, Neame Samah, Kaplan Eitan, Rosenberg Dina, Zubedat Salman, Foltyn Veronika N, Christoffersen Claus Tornby, Bundgaard Christoffer, Thomsen Christian, Avital Avi, Christensen Kenneth Vielsted, Wolosker Herman
Department of Biochemistry, Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Haifa 31096, Israel.
UMR894, Centre de Psychiatrie et Neurosciences, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Cereb Cortex. 2017 Feb 1;27(2):1573-1587. doi: 10.1093/cercor/bhv350.
d-Serine is a co-agonist of NMDA receptors (NMDARs) whose activity is potentially regulated by Asc-1 (SLC7A10), a transporter that displays high affinity for d-serine and glycine. Asc-1 operates as a facilitative transporter and as an antiporter, though the preferred direction of d-serine transport is uncertain. We developed a selective Asc-1 blocker, Lu AE00527, that blocks d-serine release mediated by all the transport modes of Asc-1 in primary cultures and neocortical slices. Furthermore, d-serine release is reduced in slices from Asc-1 knockout (KO) mice, indicating that d-serine efflux is the preferred direction of Asc-1. The selectivity of Lu AE00527 is assured by the lack of effect on slices from Asc-1-KO mice, and the lack of interaction with the co-agonist site of NMDARs. Moreover, in vivo injection of Lu AE00527 in P-glycoprotein-deficient mice recapitulates a hyperekplexia-like phenotype similar to that in Asc-1-KO mice. In slices, Lu AE00527 decreases the long-term potentiation at the Schaffer collateral-CA1 synapses, but does not affect the long-term depression. Lu AE00527 blocks NMDAR synaptic potentials when typical Asc-1 extracellular substrates are present, but it does not affect AMPAR transmission. Our data demonstrate that Asc-1 mediates tonic co-agonist release, which is required for optimal NMDAR activation and synaptic plasticity.
D-丝氨酸是N-甲基-D-天冬氨酸受体(NMDARs)的协同激动剂,其活性可能受Asc-1(溶质载体家族7成员10,SLC7A10)调节,Asc-1是一种对D-丝氨酸和甘氨酸具有高亲和力的转运体。Asc-1作为易化转运体和反向转运体发挥作用,不过D-丝氨酸转运的优先方向尚不确定。我们研发了一种选择性Asc-1阻滞剂Lu AE00527,它能在原代培养物和新皮质切片中阻断由Asc-1的所有转运模式介导的D-丝氨酸释放。此外,Asc-1基因敲除(KO)小鼠的切片中D-丝氨酸释放减少,这表明D-丝氨酸外流是Asc-1的优先方向。对Asc-1-KO小鼠的切片无影响以及与NMDARs的协同激动剂位点无相互作用确保了Lu AE00527的选择性。此外,在P-糖蛋白缺陷小鼠体内注射Lu AE00527会重现类似于Asc-1-KO小鼠的僵人综合征样表型。在切片中,Lu AE00527会降低海马体苔状纤维- CA1突触处的长时程增强,但不影响长时程抑制。当存在典型的Asc-1细胞外底物时,Lu AE00527会阻断NMDAR突触电位,但不影响AMPA受体介导的传递。我们的数据表明,Asc-1介导持续性协同激动剂释放,这是NMDAR最佳激活和突触可塑性所必需的。